Drug & Supplement Interactions

Magnesium + methylphenidate transdermal system

Brand names of methylphenidate transdermal system

  • Ritalin
  • Daytrana
  • Methylin
  • Metadate
  • Concerta
  • Quillivant
  • Aptensio
  • QuilliChew
  • Cotempla
  • Relexxii
  • Jornay

Medically reviewed by

Also reviewed by the HelloPharmacist Editorial Team

Updated July 2026Details about this page

AI is used only to summarize verified clinical information, never the open internet. Our AI policy

The Bottom Line No Known Interaction

We found no known interaction between Magnesium and methylphenidate transdermal system in our sources.

This also applies to Ritalin, Daytrana, Methylin and other brand names of methylphenidate transdermal system.

Still Worth Knowing

  • Shared side effects: Although there is no interaction, both can cause some of the same side effects. Taken together, those side effects might add up, and a new symptom can be harder to pin on one or the other.
See the Full Interaction Report

Ask a Question About This Combination

Ask in your own words about taking Magnesium with methylphenidate transdermal system. The answer comes from this page’s own records.

Try:

AI answers from this page’s interaction records and our own drug and supplement information, never the open internet. AI can make mistakes, so always check with your doctor or pharmacist. How we use AI

Interaction Report

Magnesium and methylphenidate transdermal system Interaction Check

No Known Interaction Found

We did not find a documented interaction between methylphenidate transdermal system and Magnesium in our sources. This does not guarantee that the combination is completely free of risk — there is often limited research on supplements and herbal products, especially around drug interactions.

How We Checked

Why No Interaction Is Listed for methylphenidate transdermal system

We sort drugs into categories, such as blood thinners or antibiotics, and many supplement interactions are recorded for a whole category rather than for one drug. So we checked every category methylphenidate transdermal system is in against every category Magnesium has a known interaction with.

5Categories methylphenidate transdermal system Is In
  • methylphenidate transdermal system by Name Interactions recorded for methylphenidate transdermal system itself rather than for a category. No Magnesium Record
  • Stimulant Drugs Drugs that speed up the nervous system, such as amphetamine (Adderall), methylphenidate (Ritalin) and caffeine. No Magnesium Record
  • Serotonergic Drugs Drugs that raise serotonin activity in the brain, such as many antidepressants (sertraline, fluoxetine), tramadol and triptans. No Magnesium Record
  • Serotonergic Drugs Drugs that raise serotonin activity in the brain, such as many antidepressants (sertraline, fluoxetine), tramadol and triptans. No Magnesium Record
  • Seizure Threshold Lowering Drugs Drugs that can make a seizure more likely in some people, such as bupropion, tramadol and some antibiotics. No Magnesium Record
16Drug Categories Magnesium Interacts With
Show all 16 categories

No overlap. methylphenidate transdermal system is in none of the 16 categories Magnesium interacts with, so no record links the two.

Still wondering about combining Magnesium and methylphenidate transdermal system? Ask Dr. Brian Staiger, PharmD, BCPS directly ›
Know someone taking this combination? Share
What to Watch For

Side Effects Magnesium and methylphenidate transdermal system Have in Common

16 side effects show up for both Magnesium and methylphenidate transdermal system.

  • Each has separately been linked to the effects below. Taken together, they might add up: the same side effect from two sources might be more likely or stronger. No study of the two together says by how much.
  • If one turns up, it can be harder to tell which one is behind it, so tell your pharmacist you take both.
  • 3 of them are worth acting on rather than waiting out, marked below.
  • Seizures / Raised blood pressure Worth Acting On Additional detail

    Magnesium

    Intravenously, magnesium may cause slurred speech, dizziness, drowsiness, confusion, or headaches. With toxic doses, loss of reflexes, neurological defects, drowsiness, confusion, and coma can occur.

    A case report describes cerebral cortical and subcortical edema consistent with posterior reversible encephalopathy syndrome (PRES), eclampsia, somnolence, seizures, absent deep tendon reflexes, hard to control hypertens…

    Source: , the clinical database we license.

    6 references cited
    1. 60818. Azria, E., Tsatsaris, V., Goffinet, F., Kayem, G., Mignon, A., and Cabrol, D. [Magnesium sulfate in obstetrics: current data]. J Gynecol.Obstet.Biol.Reprod.(Paris) 2004;33(6 Pt 1):510-517.
    2. 60960. Duley, L., Gulmezoglu, A. M., Henderson-Smart, D. J., and Chou, D. Magnesium sulphate and other anticonvulsants for women with pre-eclampsia. Cochrane.Database.Syst.Rev. 2010;(11):CD000025. PubMed
    3. 114681. Shepherd ES, Goldsmith S, Doyle LW, et al. Magnesium sulphate for women at risk of preterm birth for neuroprotection of the fetus. Cochrane Database Syst Rev 2024;5(5):CD004661. PubMed
    4. 8095. Birrer RB, Shallash AJ, Totten V. Hypermagnesemia-induced fatality following epsom salt gargles. J Emerg Med 2002;22:185-8. PubMed
    5. 12589. Jeyabalan A, Caritis SN. Pharmacologic inhibition of preterm labor. Clin Obstet Gynecol 2002;45:99-113. PubMed
    6. 12590. Mittendorf R, Dambrosia J, Pryde PG, et al. Association between the use of antenatal magnesium sulfate in preterm labor and adverse health outcomes in infants. Am J Obstet Gynecol 2002;186:1111-8.. PubMed

    methylphenidate transdermal system

    Source: methylphenidate transdermal system’s

    It lists this side effect in its Adverse Reactions section.

    Read methylphenidate transdermal system’s label on DailyMed ›
  • Hives Worth Acting On Additional detail

    Magnesium

    Intravenously, magnesium may cause flushing, sweating, and problems at the injection site (including burning pain). In a case study, two patients who received intravenous magnesium sulfate for suppression of preterm labor developed a rapid and sudden onset of an urticarial eruption (a skin eruption of itching welts). The eruption cleared when magnesium sulfate was discontinued.

    Source: , the clinical database we license.

    6 references cited
    1. 60960. Duley, L., Gulmezoglu, A. M., Henderson-Smart, D. J., and Chou, D. Magnesium sulphate and other anticonvulsants for women with pre-eclampsia. Cochrane.Database.Syst.Rev. 2010;(11):CD000025. PubMed
    2. 60982. Magee, L., Sawchuck, D., Synnes, A., and von, Dadelszen P. SOGC Clinical Practice Guideline. Magnesium sulphate for fetal neuroprotection. J Obstet.Gynaecol.Can. 2011;33(5):516-529.
    3. 111696. Enayati A, Gin JH, Sajeev JK, et al. Efficacy of intravenous magnesium for the management of non-post operative atrial fibrillation with rapid ventricular response: A systematic review and meta-analysis. J Cardiovasc Electrophysiol 2023;34(5):1286-1295. PubMed
    4. 114681. Shepherd ES, Goldsmith S, Doyle LW, et al. Magnesium sulphate for women at risk of preterm birth for neuroprotection of the fetus. Cochrane Database Syst Rev 2024;5(5):CD004661. PubMed
    5. 61045. Thorp, J. M., Jr., Katz, V. L., Campbell, D., and Cefalo, R. C. Hypersensitivity to magnesium sulfate. Am.J.Obstet.Gynecol. 1989;161(4):889-890. PubMed
    6. 98291. Sakanoue M, Sanada J, Kanekura T. Skin eruption elicited by magnesium oxide (Maglax). J Dermatol. 2016;43(2):221-2.

    methylphenidate transdermal system

    Source: methylphenidate transdermal system’s

    It lists this side effect in its Adverse Reactions section.

    Read methylphenidate transdermal system’s label on DailyMed ›
  • Bleeding or bruising Worth Acting On Additional detail

    Magnesium

    Intravenously, magnesium may cause increased blood loss at delivery when administered for eclampsia or pre-eclampsia. However, research on the effect of intravenous magnesium on postpartum hemorrhage is mixed.

    Source: , the clinical database we license.

    3 references cited
    1. 12592. Witlin AG, Sibai BM. Magnesium sulfate therapy in preeclampsia and eclampsia. Obstet Gynecol 1998;92:883-9.. DOI
    2. 60982. Magee, L., Sawchuck, D., Synnes, A., and von, Dadelszen P. SOGC Clinical Practice Guideline. Magnesium sulphate for fetal neuroprotection. J Obstet.Gynaecol.Can. 2011;33(5):516-529.
    3. 97489. Miller ES, Sakowicz A, Leger E. Lange E, Yee LM. The association between receipt of intrapartum magnesium and postpartum hemorrhage. Am J Obstet Gynecol 2018;218(1 Suppl):S165.

    methylphenidate transdermal system

    Source: methylphenidate transdermal system’s

    It lists this side effect in its Adverse Reactions section.

    Read methylphenidate transdermal system’s label on DailyMed ›
  • Blurred vision Additional detail

    Magnesium

    Magnesium is generally well tolerated. Some clinical research shows no differences in adverse effects between placebo and magnesium groups.

    Most Common Adverse Effects:

    Orally: Diarrhea, gastrointestinal irritation, nausea, and vomiting.

    Intravenously: Bradycardia, dizziness, flushing sensation, hypotension, and localized pain and irritation.

    Source: , the clinical database we license.

    methylphenidate transdermal system

    Source: methylphenidate transdermal system’s

    It lists this side effect in its Adverse Reactions section.

    Read methylphenidate transdermal system’s label on DailyMed ›
  • A fast or pounding heartbeat Additional detail

    Magnesium

    Intravenously, magnesium can cause bradycardia, tachycardia, and hypotension. Inhaled magnesium administered by nebulizer may also cause hypotension. Magnesium sulfate may cause rapid heartbeat when administered antenatally.

    In one case report, a 99-year-old male who took oral magnesium oxide 3000 mg daily for chronic constipation was hospitalized with hypermagnesemia, hypotension, bradycardia, heart failure, cardiom…

    Source: , the clinical database we license.

    6 references cited
    1. 13356. Davey MJ, Teubner D. A randomized controlled trial of magnesium sulfate, in addition to usual care, for rate control in atrial fibrillation. Ann Emerg Med 2005;45:347-53.. PubMed
    2. 60795. Horner, S. M. Efficacy of intravenous magnesium in acute myocardial infarction in reducing arrhythmias and mortality. Meta-analysis of magnesium in acute myocardial infarction. Circulation 1992;86(3):774-779. PubMed
    3. 60838. Henyan, N. N., Gillespie, E. L., White, C. M., Kluger, J., and Coleman, C. I. Impact of intravenous magnesium on post-cardiothoracic surgery atrial fibrillation and length of hospital stay: a meta-analysis. Ann.Thorac.Surg. 2005;80(6):2402-2406. PubMed
    4. 60872. Li, J., Zhang, Q., Zhang, M., and Egger, M. Intravenous magnesium for acute myocardial infarction. Cochrane.Database.Syst.Rev. 2007;(2):CD002755. PubMed
    5. 60960. Duley, L., Gulmezoglu, A. M., Henderson-Smart, D. J., and Chou, D. Magnesium sulphate and other anticonvulsants for women with pre-eclampsia. Cochrane.Database.Syst.Rev. 2010;(11):CD000025. PubMed
    6. 60973. Wong, G. K., Boet, R., Poon, W. S., Chan, M. T., Gin, T., Ng, S. C., and Zee, B. C. Intravenous magnesium sulphate for aneurysmal subarachnoid hemorrhage: an updated systemic review and meta-analysis. Crit Care 2011;15(1):R52. PubMed

    methylphenidate transdermal system

    Source: methylphenidate transdermal system’s

    It lists this side effect in its Adverse Reactions section.

    Read methylphenidate transdermal system’s label on DailyMed ›
  • Drowsiness / Swelling Additional detail

    Magnesium

    Recorded for Magnesium in the same Natural Medicines adverse-effect record shown under Seizures / Raised blood pressure above.

    methylphenidate transdermal system

    Source: methylphenidate transdermal system’s

    It lists this side effect in its Adverse Reactions section.

    Read methylphenidate transdermal system’s label on DailyMed ›
  • Reduced appetite Additional detail

    Magnesium

    Orally, magnesium can cause gastrointestinal irritation, nausea, vomiting, and diarrhea. In rare cases, taking magnesium orally might cause a bezoar, an indigestible mass of material which gets lodged in the gastrointestinal tract. In a case report, a 75-year-old female with advanced rectal cancer taking magnesium 1500 mg daily presented with nausea and anorexia from magnesium oxide bezoars in her stomach.

    Source: , the clinical database we license.

    6 references cited
    1. 1194. Dahle LO, Berg G, Hammar M, et al. The effect of oral magnesium substitution on pregnancy-induced leg cramps. Am J Obstet Gynecol 1995;173:175-80. PubMed
    2. 4891. Peikert A, Wilimzig C, Kohne-Volland R. Prophylaxis of migraine with oral magnesium: results from a prospective, multi-center, placebo-controlled and double-blind randomized study. Cephalalgia 1996;16:257-63. PubMed
    3. 10661. Pfaffenrath V, Wessely P, Meyer C, et al. Magnesium in the prophylaxis of migraine--a double-blind placebo-controlled study. Cephalalgia 1996;16:436-40.. PubMed
    4. 10663. Wang F, Van Den Eeden SK, Ackerson LM, et al. Oral magnesium oxide prophylaxis of frequent migrainous headache in children: a randomized, double-blind, placebo-controlled trial. Headache 2003;43:601-10.. PubMed
    5. 18111. Kass L, Weekes J, Carpenter L. Effect of magnesium supplementation on blood pressure: a meta-analysis. Eur J Clin Nutr 2012;66:411-8. PubMed
    6. 60951. Han, S., Crowther, C. A., and Moore, V. Magnesium maintenance therapy for preventing preterm birth after threatened preterm labour. Cochrane.Database.Syst.Rev. 2010;(7):CD000940. PubMed

    methylphenidate transdermal system

    Source: methylphenidate transdermal system’s

    It lists this side effect in its Adverse Reactions section.

    Read methylphenidate transdermal system’s label on DailyMed ›
  • Itching Additional detail

    Magnesium

    Recorded for Magnesium in the same Natural Medicines adverse-effect record shown under Hives above.

    methylphenidate transdermal system

    Source: methylphenidate transdermal system’s

    It lists this side effect in its Adverse Reactions section.

    Read methylphenidate transdermal system’s label on DailyMed ›

Showing the 10 most notable of 16 shared effects — ranked by how unusual each one is, not just whether both lists mention it.

Reported for Magnesium but not commonly for methylphenidate transdermal system: a bowel blockage, trouble passing urine, muscle weakness and kidney problems.

Note: Effects for methylphenidate transdermal system come from the Adverse Reactions section of its FDA label; effects for Magnesium come from the Natural Medicines adverse-effect record, quoted above. The two sources word some effects differently, so we match them by meaning.

If You Decide to Take Both
  • Add one new thing at a time, and note the date you started it.
  • A start date turns “I’ve been feeling off” into something a pharmacist can work with.
  • Do not stop a prescribed medicine on your own.
  • Check with your pharmacist or doctor before changing any medicine or supplement, especially if you take several or have an ongoing health condition.

Beyond the Record

What Else We Found About Magnesium and methylphenidate transdermal system

Pharmacist Q&AYou ask. We answer.

Questions Our Pharmacists Have Answered About Magnesium and methylphenidate transdermal system

Real questions from readers, each answered by a licensed pharmacist at HelloPharmacist, written by a person and not generated from a database. An answer is written for the reader who asked and their situation, so read it for what to ask your own pharmacist rather than as a plan to follow.

Each one covers Magnesium or methylphenidate transdermal system, not necessarily both.

  1. The pharmacist says

    Magnesium oxide has been shown in human studies to lower blood levels of both levodopa and carbidopa.

    Answered by Dr. Brian Staiger, PharmD · October 2026
  2. The pharmacist says

    Magnesium glycinate is not expected to interact with Effexor (venlafaxine), so it is generally considered a reasonable supplement to take alongside it.

    Answered by Dr. Brian Staiger, PharmD · October 2026
  3. The pharmacist says

    Most people can take magnesium and CoQ10 with Eliquis without problems, though these combinations haven't been formally studied enough for a definitive safety statement. Magnesium has only a minor interaction rating with Eliquis and hasn't been shown to increase bleeding risk at supplement doses, though your doctor should know you're taking it especially if you have kidney issues. CoQ10 doesn't carry the vitamin K concerns it does with warfarin since Eliquis works through a different mechanism, and it's considered low concern rather than proven safe. Watch for bleeding signs like unexplained bruises, nosebleeds, pink or red urine, or black stools, and have your pharmacist review the specific products you plan to use since combination supplements may contain additional ingredients that matter more than the main active ingredients.

    Answered by Dr. Brian Staiger, PharmD · October 2026
  4. The pharmacist says

    Opening a plain magnesium glycinate capsule and mixing the powder into yogurt is safe and won't reduce how well it works since the gelatin shell dissolves in your stomach anyway. Check your label first to confirm it doesn't say "do not open," "delayed release," or "enteric coated," since those types need to stay intact. Mix the powder into a small spoonful of thick food like yogurt right before taking it, and finish the whole dose so nothing gets left behind. Magnesium can interact with certain medications like antibiotics and thyroid drugs, so take it a few hours apart from those medicines if you use them.

    Answered by Dr. Brian Staiger, PharmD · September 2026
Published Research

Has Anyone Studied Magnesium With methylphenidate transdermal system?

No published study names both Magnesium and methylphenidate transdermal system. We searched . Most supplement and drug pairs have never been studied together.

Reports to the FDA

28 reports to the FDA list both Magnesium and methylphenidate transdermal system.

What this means: someone took both, then had a health problem. It does not show either one caused it. In 2 of the 5 newest reports, Magnesium or methylphenidate transdermal system was the suspect or was flagged as interacting. The reports below say which.

  • 28Reports that list both
  • 15Marked serious by the reporter
  • 4From doctors, pharmacists and other health professionals
  • 10From patients and other consumers
The 5 Newest Reports
Who sent them, what happened and which medicine was suspected
ReceivedReported byWhat happenedMedicine suspectedMagnesiummethylphenidate transdermal system
May 2021Report 19289089 A consumer Device adhesion issue, Device breakage, Device difficult to useSerious: medically important Daytrana17 products listed Also taking Suspected
May 2021Report 19271963 A consumer Adhesive tape use, Product administered at inappropriate site, Device difficult to use Daytrana17 products listed Also taking Suspected
September 2020Report 18324496 Another health professional Therapeutic procedure, Abdominal operation, NauseaSerious: medically important Xyrem23 products listed Also taking Also taking
March 2020Report 17551887 Another health professional Thoughts of self-harm (suicidal ideation), Hyperoxaluria, Bone thinning (osteoporosis)Serious: medically important Xyrem29 products listed Also taking Also taking
October 2019Report 16927465 A physician Raised blood pressure (hypertension), Surgery, DehydrationSerious: medically important Xyrem48 products listed Also taking Also taking
Problems Named Most Often

Across all 28 reports, whatever was suspected. Not what this pair causes.

  • Low mood (depression)4
  • Pain3
  • Adhesive tape use2
  • Aggravated condition2
  • Crying2
  • Dehydration2
How we searched

PubMed: searched October 2026, and again every few months. PubMed lists research but does not grade it; the finding above comes from our interaction records.

FDA reports: from the FDA Adverse Event Reporting System (FAERS) through openFDA, read October 2026. Matched by name, so a report may name a product that contains Magnesium. The counts are reports, not people, and no one checks them for cause. What FAERS is.

Your Whole Routine

Your Other Medicines and Supplements

Keep It in Perspective

Magnesium Does Interact With Other Medications

Magnesium has 6 major, 178 moderate, 114 minor known drug interactions in our database — methylphenidate transdermal system isn’t one of them. If you take anything else, check it against the full list below.

Taking Anything Else?

Check Another of Your Medications Against Magnesium

Covers the 2,830 medications we’ve checked against Magnesium. Pick one to open its full report.

Alternatives for the Same Use

Other Supplements for the Same Uses as Magnesium, and How They Mix With methylphenidate transdermal system

Choosing a supplement while you take methylphenidate transdermal system? Pick what you use Magnesium for to see other options studied for it, and whether each has a documented interaction with methylphenidate transdermal system.

What do you take Magnesium for?

For Constipation

None of them has a documented interaction with methylphenidate transdermal system.

22 other supplements have at least some evidence of a benefit for constipation; the 8 below come first. Magnesium itself is graded for it.

For Dyspepsia

None of them has a documented interaction with methylphenidate transdermal system.

11 other supplements have at least some evidence of a benefit for dyspepsia; the 8 below come first. Magnesium itself is graded for it.

For Bowel Preparation

None of them has a documented interaction with methylphenidate transdermal system.

4 other supplements have at least some evidence of a benefit for bowel preparation. Magnesium itself is graded for it.

  • Phosphate Salts Graded No Known Interaction
  • Castor Bean Graded No Known Interaction
  • Senna Graded No Known Interaction
  • Vitamin C Graded No Known Interaction

For Pre-eclampsia

None of them has a documented interaction with methylphenidate transdermal system.

3 other supplements have at least some evidence of a benefit for pre-eclampsia. Magnesium itself is graded for it.

  • Calcium Graded No Known Interaction
  • L-arginine Graded No Known Interaction
  • Selenium Graded No Known Interaction

For Seizures

None of them has a documented interaction with methylphenidate transdermal system.

2 other supplements have at least some evidence of a benefit for seizures. Magnesium itself is graded for it.

For Hypercholesterolemia

2 of them have a documented interaction with methylphenidate transdermal system: Black Seed (moderate) and Green Tea (moderate).

40 other supplements have at least some evidence of a benefit for hypercholesterolemia; the 8 below come first. Magnesium itself is graded for it.

  • Black Seed Graded Moderate
  • Green Tea Graded Moderate
  • Barley Graded No Known Interaction
  • Beta-glucans Graded No Known Interaction
  • Blond Psyllium Graded No Known Interaction
  • Oats Graded No Known Interaction
  • Plant Sterols Graded No Known Interaction
  • Alpha-lipoic Acid Graded No Known Interaction

The grades come from the Natural Medicines database and describe the research so far, not a recommendation, and none of these supplements replaces a prescribed medicine.

Everything Else You Take

See Every Supplement That Interacts With methylphenidate transdermal system

Take other supplements too? 68 supplements have a documented interaction with methylphenidate transdermal system, each explained on its page.

By severity: 5 major, 57 moderate and 6 minor.

The Most Serious There Right Now:

Open the methylphenidate transdermal system interaction pageEvery supplement checked against methylphenidate transdermal system, ranked by severity
One More Smart Check

Taking Magnesium as Part of a Dietary Supplement Product? Check It for Interactions

A product can hold more than Magnesium. We have broken down 29,723 supplement products that contain it, ingredient by ingredient. Find yours and we’ll check every ingredient against methylphenidate transdermal system:

Get to Know Each One

About Magnesium and methylphenidate transdermal system

Supplement

About Magnesium

Magnesium

Magnesium is an essential mineral your body needs for muscles, nerves, blood pressure, and many other functions, and supplements are useful for preventing or correcting deficiency. Some other uses, like easing constipation or preventing migraines, have reasonable support, while uses for sleep and anxiety are less proven. It is generally safe for most healthy people at recommended amounts, but talk to your pharmacist or doctor before starting, especially if you have kidney problems.

Full Magnesium guide: uses, dosage, safety and every interaction

On Its Own

Magnesium Safety

Safety at a Glance

How Magnesium Is Rated

  • Magnesium Overall

    Generally safe

    Generally safe for healthy adults when taken at recommended amounts from food and supplements.

  • Pregnancy

    Likely Safe

    When used orally and appropriately. Magnesium is safe for those pregnant and breast-feeding when used in doses below the tolerable upper intake level (UL) of 350 mg daily.

    Read the full pregnancy detail ↓
  • Breastfeeding

    Likely Safe

    When used orally and appropriately. Magnesium is safe for those pregnant and breast-feeding when used in doses below the tolerable upper intake level (UL) of 350 mg daily.

    Read the full breastfeeding detail ↓

Pregnancy & breastfeeding ratings are from Natural Medicines (Therapeutic Research Center), with the full detail in the next card.

Special Populations

Magnesium in Pregnancy & Breastfeeding

Pregnancy And Lactation Likely Safe

When used orally and appropriately. Magnesium is safe for those pregnant and breast-feeding when used in doses below the tolerable upper intake level (UL) of 350 mg daily.

Pregnancy And Lactation Possibly Safe

When prescription magnesium sulfate is given intramuscularly and intravenously prior to delivery for up to 5 days. However, due to potential adverse effects associated with intravenous and intramuscular magnesium, use during pregnancy is limited to patients with specific conditions such as severe pre-eclampsia or eclampsia. There is some evidence that intravenous magnesium can increase fetal mortality and adversely affect neurological and skeletal development. However, a more recent analysis of clinical research shows that increased risk of fetal mortality seems to occur only in the studies where antenatal magnesium is used for tocolysis and not for fetal neuroprotection or pre-eclampsia/eclampsia. Furthermore, antenatal magnesium does not seem to be associated with increased risk of necrotizing enterocolitis in preterm infants. There is also concern that magnesium increases the risk of maternal adverse events. A meta-analysis of clinical research shows that magnesium sulfate might increase the risk of maternal adverse events, especially in Hispanic mothers compared to other racial and ethnic groups.

Pregnancy And Lactation Possibly Unsafe

When used orally in excessive doses. Tell patients to avoid exceeding the tolerable upper intake level (UL) of 350 mg daily. Taking magnesium orally in higher doses can cause diarrhea. ...when prescription magnesium sulfate is given intramuscularly and intravenously prior to delivery for longer than 5 days. Maternal exposure to magnesium for longer than 5-7 days is associated with an increase in neonatal bone abnormalities such as osteopenia and fractures. The U.S. Food and Drug Administration (FDA) recommends that magnesium injection not be given for longer than 5-7 days.

DISCLAIMER: This tool is intended for informational purposes only, and should not be interpreted as specific medical advice. Patients should consult with a qualified healthcare provider before making decisions about therapies and/or health conditions.© 2026 Therapeutic Research Center

Medication

About Methylphenidate Transdermal Patch

Brand names: Ritalin, Daytrana, Methylin, Metadate, Concerta, Quillivant, Aptensio, QuilliChew, Cotempla, Relexxii, Jornay

Methylphenidate Transdermal System (sold as Daytrana and as a generic Methylphenidate Transdermal System) treats ADHD in patients 6 to 17 years of age. It is a central nervous system (CNS) stimulant.

Methylphenidate Transdermal Patch: uses, dosage and side effects Methylphenidate Transdermal Patch: interactions with other drugs Taking more than these two? Check Magnesium and Methylphenidate Transdermal Patch with everything else you take Methylphenidate NDC codes and packages

More to Explore

More Pairs and Interactions to Check

Keep Checking

Other Drugs & Magnesium

Browse every other medication we’ve checked against Magnesium — both the ones with a known interaction and the ones without. Select any drug for the full detail.

6Major
178Moderate
114Minor
2,531No known interaction
Major

Major: 6 interactions

Moderate

Moderate: 178 interactions

Showing 60 of 178 moderate interactions — see all 178 on the Magnesium page.

Minor

Minor: 114 interactions

Showing 60 of 114 minor interactions — see all 114 on the Magnesium page.

No Interaction 2,531 drugs checked — show the list

We also checked Magnesium against these medications and found no known interaction in our sources. Open any page to confirm.

Showing 60 of the 2,531 medications checked with no known interaction, the most looked-up first — see the full Magnesium list.

How Much People Look This Up

Where Magnesium and methylphenidate transdermal system Sit Against Everything Else

Out of every supplement and medication people look up on HelloPharmacist, here is where these two land this week — and which way each has been moving.

Supplement Magnesium
Top 10

#3 of 1,458 supplements looked up here in the last 7 days

29 days ago today
Medication methylphenidate transdermal system
Top 10%

#183 of 2,830 medications looked up here in the last 7 days

29 days ago today

A rank of lookups on this site, not of how often either one is used. It counts every visit, automated ones included, and identifies no one.

Questions and Sources

Common Questions and Where This Comes From

Pharmacist Counseling Corner

Taking Magnesium and methylphenidate transdermal system Together: Common Questions

Can you take Magnesium with methylphenidate transdermal system?
We do not list a known interaction between Magnesium and methylphenidate transdermal system. That does not guarantee the combination is risk-free, so confirm with your pharmacist or doctor — especially if you take other medications or have a health condition.
Can you take Magnesium with Ritalin?
Ritalin is a brand name of methylphenidate transdermal system, and so are Daytrana and Methylin, so the answer is the same as for methylphenidate transdermal system. We do not list a known interaction between Magnesium and methylphenidate transdermal system. Everything on this page applies to Ritalin too.
Do Magnesium and methylphenidate transdermal system have any of the same side effects?
Yes — our sources link each of them separately to 10 of the same effects. That is not a documented interaction, but taken together the same side effect from two sources might be more likely or stronger; no study of the two together says by how much. And if one of those effects turns up, it can be harder to tell which one is behind it. They are listed on this page with the source behind each.
How was the Magnesium and methylphenidate transdermal system combination checked?
Interactions in our licensed database are recorded against drug classes. methylphenidate transdermal system is filed under 5 classifications, and Magnesium has documented interactions with 16 drug classes — none of methylphenidate transdermal system's classifications are among them. A medication can belong to classes beyond those recorded in our dataset, so this describes how the check was run rather than guaranteeing safety.
Do other supplements studied for constipation interact with methylphenidate transdermal system?
None of the 22 other supplements the Natural Medicines database grades as having some evidence of a benefit for constipation has a documented interaction with methylphenidate transdermal system. A grade is the research so far, not a recommendation, and no known interaction is not proof of safety; ask your pharmacist before adding one.
Does Magnesium interact with any other medications?
Yes. Magnesium has 298 documented drug interactions in our database — methylphenidate transdermal system is simply not one of them. If you take anything else, it is worth checking each one; they are all listed on this page.
Does methylphenidate transdermal system interact with any supplements?
Yes. methylphenidate transdermal system has documented interactions with 68 supplements in our database — Magnesium is not one of them. The methylphenidate transdermal system interaction page linked on this page lists every one, ranked by severity.
Has Magnesium been studied with methylphenidate transdermal system?
We searched PubMed, the National Library of Medicine's index of medical research, in October 2026, and found no study that names both Magnesium and methylphenidate transdermal system. Most supplement and drug pairs have never been studied together, so no known interaction is not the same as proven safe.

Written and reviewed by the HelloPharmacist Editorial Team. Our editorial policy

Evidence & Sources

References Cited on This Page

The 23 references the cards above cite, from the evidence-graded Natural Medicines (TRC Healthcare) database. Citations with a link open the study on PubMed or the publisher’s site.

Show the 23 references
  1. 1194. Dahle LO, Berg G, Hammar M, et al. The effect of oral magnesium substitution on pregnancy-induced leg cramps. Am J Obstet Gynecol 1995;173:175-80. PubMed
  2. 4891. Peikert A, Wilimzig C, Kohne-Volland R. Prophylaxis of migraine with oral magnesium: results from a prospective, multi-center, placebo-controlled and double-blind randomized study. Cephalalgia 1996;16:257-63. PubMed
  3. 8095. Birrer RB, Shallash AJ, Totten V. Hypermagnesemia-induced fatality following epsom salt gargles. J Emerg Med 2002;22:185-8. PubMed
  4. 10661. Pfaffenrath V, Wessely P, Meyer C, et al. Magnesium in the prophylaxis of migraine--a double-blind placebo-controlled study. Cephalalgia 1996;16:436-40.. PubMed
  5. 10663. Wang F, Van Den Eeden SK, Ackerson LM, et al. Oral magnesium oxide prophylaxis of frequent migrainous headache in children: a randomized, double-blind, placebo-controlled trial. Headache 2003;43:601-10.. PubMed
  6. 12589. Jeyabalan A, Caritis SN. Pharmacologic inhibition of preterm labor. Clin Obstet Gynecol 2002;45:99-113. PubMed
  7. 12590. Mittendorf R, Dambrosia J, Pryde PG, et al. Association between the use of antenatal magnesium sulfate in preterm labor and adverse health outcomes in infants. Am J Obstet Gynecol 2002;186:1111-8.. PubMed
  8. 12592. Witlin AG, Sibai BM. Magnesium sulfate therapy in preeclampsia and eclampsia. Obstet Gynecol 1998;92:883-9.. DOI
  9. 13356. Davey MJ, Teubner D. A randomized controlled trial of magnesium sulfate, in addition to usual care, for rate control in atrial fibrillation. Ann Emerg Med 2005;45:347-53.. PubMed
  10. 18111. Kass L, Weekes J, Carpenter L. Effect of magnesium supplementation on blood pressure: a meta-analysis. Eur J Clin Nutr 2012;66:411-8. PubMed
  11. 60795. Horner, S. M. Efficacy of intravenous magnesium in acute myocardial infarction in reducing arrhythmias and mortality. Meta-analysis of magnesium in acute myocardial infarction. Circulation 1992;86(3):774-779. PubMed
  12. 60818. Azria, E., Tsatsaris, V., Goffinet, F., Kayem, G., Mignon, A., and Cabrol, D. [Magnesium sulfate in obstetrics: current data]. J Gynecol.Obstet.Biol.Reprod.(Paris) 2004;33(6 Pt 1):510-517.
  13. 60838. Henyan, N. N., Gillespie, E. L., White, C. M., Kluger, J., and Coleman, C. I. Impact of intravenous magnesium on post-cardiothoracic surgery atrial fibrillation and length of hospital stay: a meta-analysis. Ann.Thorac.Surg. 2005;80(6):2402-2406. PubMed
  14. 60872. Li, J., Zhang, Q., Zhang, M., and Egger, M. Intravenous magnesium for acute myocardial infarction. Cochrane.Database.Syst.Rev. 2007;(2):CD002755. PubMed
  15. 60951. Han, S., Crowther, C. A., and Moore, V. Magnesium maintenance therapy for preventing preterm birth after threatened preterm labour. Cochrane.Database.Syst.Rev. 2010;(7):CD000940. PubMed
  16. 60960. Duley, L., Gulmezoglu, A. M., Henderson-Smart, D. J., and Chou, D. Magnesium sulphate and other anticonvulsants for women with pre-eclampsia. Cochrane.Database.Syst.Rev. 2010;(11):CD000025. PubMed
  17. 60973. Wong, G. K., Boet, R., Poon, W. S., Chan, M. T., Gin, T., Ng, S. C., and Zee, B. C. Intravenous magnesium sulphate for aneurysmal subarachnoid hemorrhage: an updated systemic review and meta-analysis. Crit Care 2011;15(1):R52. PubMed
  18. 60982. Magee, L., Sawchuck, D., Synnes, A., and von, Dadelszen P. SOGC Clinical Practice Guideline. Magnesium sulphate for fetal neuroprotection. J Obstet.Gynaecol.Can. 2011;33(5):516-529.
  19. 61045. Thorp, J. M., Jr., Katz, V. L., Campbell, D., and Cefalo, R. C. Hypersensitivity to magnesium sulfate. Am.J.Obstet.Gynecol. 1989;161(4):889-890. PubMed
  20. 97489. Miller ES, Sakowicz A, Leger E. Lange E, Yee LM. The association between receipt of intrapartum magnesium and postpartum hemorrhage. Am J Obstet Gynecol 2018;218(1 Suppl):S165.
  21. 98291. Sakanoue M, Sanada J, Kanekura T. Skin eruption elicited by magnesium oxide (Maglax). J Dermatol. 2016;43(2):221-2.
  22. 111696. Enayati A, Gin JH, Sajeev JK, et al. Efficacy of intravenous magnesium for the management of non-post operative atrial fibrillation with rapid ventricular response: A systematic review and meta-analysis. J Cardiovasc Electrophysiol 2023;34(5):1286-1295. PubMed
  23. 114681. Shepherd ES, Goldsmith S, Doyle LW, et al. Magnesium sulphate for women at risk of preterm birth for neuroprotection of the fetus. Cochrane Database Syst Rev 2024;5(5):CD004661. PubMed

All 84 references behind our Magnesium records are listed in the Magnesium guide.

Medication overviews come from MedlinePlus (NIH); supplement label data from the NIH Dietary Supplement Label Database. Content is reviewed by the HelloPharmacist Editorial Team. See our data sources and editorial standards.

Where Does Our Data Come From?
  • Source: the Natural Medicines (TRC Healthcare) clinical database — the evidence-graded professional reference for herb & supplement interactions.
  • Citation library: 105,612 references behind our interaction content, 67,053 of them resolved to verified PubMed/DOI sources. See the references behind this page ↓
  • Freshness: we automatically re-check this combination every week — this pair was last verified November 15, 2026. The Magnesium and methylphenidate transdermal system records this page draws on were last updated July 10, 2026.
Data structure & sourcing designed and verified by .
Rating Key

What Our Interaction Ratings Mean

No interaction is on record for this pair. The other supplements and medicines on this page carry a severity rating: how serious an interaction between them is.

See what each severity means

Severity: How Serious Is It?

How clinically significant the interaction is: how much it could affect your health or your treatment.

  • MajorClinically significant. Best to avoid the combination, or use only under close professional supervision.
  • ModerateBe cautious. The combination may call for monitoring, timing changes, or a dose adjustment.
  • MinorLimited clinical concern, but still worth being aware of and mentioning to your pharmacist.
  • No Known InteractionNo documented interaction in our sources.

Still Have a Question About Magnesium and methylphenidate transdermal system?

Our pharmacists answer your medication & supplement questions — free.

Ask a pharmacist

This information is for education only and is not a substitute for professional medical advice. Always check with your pharmacist or doctor before starting, stopping, or combining supplements and medications.